Supporting HIV care through education and innovation

Integrating the Prevention and Treatment of Hepatitis C with the Treatment of HIV/AIDS: ADAP TA Call

Integrating the Prevention and Treatment of Hepatitis C with the Treatment of HIV/AIDS: ADAP TA Call

July 1, 2000
HRSA HIV/AIDS Bureau

Description

Overview of hepatitis C virus (HCV) and how and when to treat patients co-infected with HIV and HCV. The New York Title II grantee addresses how it became aware of HCV treatment and added Rebetron to its formulary. The California Title II grantee reviews its experience in adding HCV drugs to its formulary. The New Jersey grantee presents its approach to adding HCV drugs to the State formulary.

Add a Comment

Log in or register to post comments